Literature DB >> 22622138

Type III procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion.

Mitsuharu Kawamura1, Yumi Munetsugu, Shiro Kawasaki, Katsumi Onishi, Yoshimasa Onuma, Miwa Kikuchi, Kaoru Tanno, Youichi Kobayashi.   

Abstract

AIMS: Fibrosis and inflammation may play a significant role in the pathogenesis of atrial fibrillation (AF) recurrence. Type III procollagen-N-peptide (PIIINP) may be related to atrial fibrosis and play a role in predicting the recurrence of AF. We investigated whether PIIINP as a fibrosis marker predicts the recurrence of AF after cardioversion. METHODS AND
RESULTS: Serum PIIINP, interleukin-6, high-sensitivity C-reactive protein, brain natriuretic peptide, renin and aldosterone were measured at baseline and 24 months in 88 patients (62%) with sinus rhythm (SR) maintenance and 54 patients (38%) with AF recurrence. Furthermore, the root mean square voltage in the last 20 ms (RMS20) via P-wave signal-averaged electrocardiogram (P-SAECG) was measured and the relationship between fibrosis biomarkers and RMS20 was examined. Baseline PIIINP with AF recurrence was significantly higher than for those with SR maintenance (0.664 vs. 0.581 U/mL, P = 0.001). However, there were no significant differences in other biomarkers. A logistic regression identified PIIINP (odds ratio 2.61, P = 0.008) as an independent predictor of AF recurrence. The RMS20 as measured by P-SAECG with SR maintenance and PIIINP levels <0.72 U/mL (at baseline) was significantly higher after 24 months than at baseline. Furthermore, the RMS20 with AF recurrence and PIIINP levels >0.72 U/mL (at baseline) was significantly lower after 24 months than baseline.
CONCLUSIONS: Elevated baseline PIIINP concentration is an independent predictor for AF recurrence after cardioversion. Furthermore, there is a relationship between PIIINP and RMS20 and the fibrosis of AF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622138     DOI: 10.1093/europace/eus162

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  11 in total

1.  Left atrial pressure as predictor for recurrence of atrial fibrillation after pulmonary vein isolation.

Authors:  Markus Linhart; Thorsten Lewalter; Erica L Mittmann-Braun; Nicole C Karbach; René P Andrié; Christoph Hammerstingl; Rolf Fimmers; Jens Kreuz; Georg Nickenig; Jan W Schrickel; Lars M Lickfett
Journal:  J Interv Card Electrophysiol       Date:  2013-06-23       Impact factor: 1.900

2.  Relationship between electrical conduction and phasic left atrial function: P-wave signal-averaged electrocardiography and time-left atrial volume curve assessments using two-dimensional speckle-tracking echocardiography.

Authors:  Shinichiro Tanaka; Toshiyuki Noda; Masanori Kawasaki; Tomonori Segawa; Natsumi Tsugita; Takahiro Fuseya; Tomoki Kubota; Makoto Iwama; Kazuhiko Nishigaki; Sachiro Watanabe; Taro Minagawa; Hiroshige Ohashi; Shinya Minatoguchi
Journal:  Heart Vessels       Date:  2019-01-25       Impact factor: 2.037

3.  Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.

Authors:  Theodoros A Zografos; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

4.  The N-terminal propeptide of type III procollagen in patients with acute coronary syndrome: a link between left ventricular end-diastolic pressure and cardiovascular events.

Authors:  Cheng-Hung Lee; Wen-Chen Lee; Shang-Hung Chang; Ming-Shien Wen; Kuo-Chun Hung
Journal:  PLoS One       Date:  2015-01-05       Impact factor: 3.240

Review 5.  Relationship between Brain Natriuretic Peptide and Recurrence of Atrial Fibrillation after Successful Electrical Cardioversion: an Updated Meta-Analysis.

Authors:  Xiangdong Xu; Yongqing Tang
Journal:  Braz J Cardiovasc Surg       Date:  2017 Nov-Dec

6.  Atrial fibrosis underlying atrial fibrillation (Review).

Authors:  Chang Yi Li; Jing Rui Zhang; Wan Ning Hu; Song Nan Li
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

7.  Therapeutic implications of galectin-3 in patients with atrial fibrillation.

Authors:  Kwang-No Lee; Do Young Kim; Ki Yung Boo; Yun Gi Kim; Seung-Young Roh; Yong-Soo Baek; Dong-Hyeok Kim; Dae In Lee; Jaemin Shim; Jong-Il Choi; Gyo-Seung Hwang; Young-Hoon Kim
Journal:  Sci Rep       Date:  2022-01-17       Impact factor: 4.379

8.  Type III procollagen peptide level can indicate liver dysfunction associated with volume overload in acute heart failure.

Authors:  Akihiro Shirakabe; Hirotake Okazaki; Masato Matsushita; Yusaku Shibata; Shota Shigihara; Suguru Nishigoori; Tomofumi Sawatani; Nozomi Sasamoto; Kazutaka Kiuchi; Masanori Atsukawa; Norio Itokawa; Taeang Arai; Nobuaki Kobayashi; Kuniya Asai
Journal:  ESC Heart Fail       Date:  2022-03-14

9.  Chloride Channels are Involved in the Development of Atrial Fibrillation - A Transcriptomic and proteomic Study.

Authors:  Yi-Yao Jiang; Hai-Tao Hou; Qin Yang; Xiao-Cheng Liu; Guo-Wei He
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

10.  Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome.

Authors:  Valery A Ionin; Elena I Baranova; Ekaterina L Zaslavskaya; Elena Yu Petrishcheva; Aleksandr N Morozov; Evgeny V Shlyakhto
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.